The profiling of AML patient specimens revealed a change in H3K9me3 levels between two subsets of AML samples, which was paralleled by changes in the gene expression levels of SETDB1, one of the methyltransferases responsible for the trimethylation of H3K9 [47]. This evidence concerns the gene SETDB1 and acute myeloid leukemia.